Efficacy and Safety of Minocycline-Containing Bismuth Quadruple Therapies Versus Standard First-Line Bismuth Quadruple Therapies for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis
the number of included RCTs was modest, with only five studies meeting eligibility criteria, and only two contributing to the modified intention-to-treat analysis. The risk-of-bias assessment showed variation in methodological quality across the included studies. Several studies exhibited high risk judgments in critical domains. particularly randomization, deviations from intervention, and selective reporting. Patients who completed the treatment benefited more from MBQT, which also had a comparable safety profile to conventional BQT regimens. In the treatment of <i>H. pylori</i> infection, MBQT may be considered a safe alternative for first-line treatment.
Authors
- Noora Inam
- Ussama Shafaqat
- Hafsa Parveen
- Anum Zia Khan
- Hafsa Ajmal
- Yousra Iftequar
- Hafiz Muhammad Moaaz Sajid
- I M Khalid Reza
- Nayanika Tummala
- Hakim Ullah Wazir
- Zeeshan Ahmed
- Abdul Muqeet Khuram
- Ilyas Muhammad Sulaiman
Institutions
- King Edward Medical University (PK)
- University of Louisville (US)
- Punjab Medical College (PK)
- St. Mary Medical Center (US)
- Jinnah Sindh Medical University (PK)
- University College for Women (IN)
- Women Medical College (PK)
- University of Swabi (PK)
- Mayo Hospital (PK)
- UConn Health (US)
- Dhaka Medical College and Hospital (BD)
Publication Details
- Journal
- Infectious Disease Reports
- Published
- 2026-02-06
- DOI
- https://doi.org/10.3390/idr18010016
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00